Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments
Deep brain stimulation (DBS) has been successfully used to treat movement disorders, such as Parkinson's disease, for more than 25 years and heralded the advent of electrical neuromodulation to treat diseases with dysregulated neuronal circuits. DBS is now superseding ablative techniques, such...
Saved in:
Published in | EMBO molecular medicine Vol. 11; no. 4 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Germany
EMBO Press
01.04.2019
John Wiley and Sons Inc Springer Nature |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Deep brain stimulation (DBS) has been successfully used to treat movement disorders, such as Parkinson's disease, for more than 25 years and heralded the advent of electrical neuromodulation to treat diseases with dysregulated neuronal circuits. DBS is now superseding ablative techniques, such as stereotactic radiofrequency lesions. While serendipity has played a role in developing DBS as a therapy, research during the past two decades has shown that electrical neuromodulation is far more than a functional lesion that can be switched on and off. This understanding broadens the field to enable new types of stimulation, clinical indications, and research. This review highlights the complex effects of DBS from the single cell to the neuronal network. Specifically, we examine the electrical, cellular, molecular, and neurochemical mechanisms of DBS as applied to Parkinson's disease and other emerging applications.
For over 25 years, deep brain stimulation (DBS) has been successfully used to treat movement disorders, i.e. Parkinson's disease. With high precision stereotactic implantation of electrodes, DBS is fast becoming a powerful tool for studying and treating the brain against many different diseases. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 See the Glossary for abbreviations used in this article. |
ISSN: | 1757-4676 1757-4684 1757-4684 |
DOI: | 10.15252/emmm.201809575 |